These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6512448)

  • 1. Incidence of anemia in leprosy patients treated with dapsone.
    Puavilai S; Chutha S; Polnikorn N; Timpatanapong P; Tasanapradit P; Charuwichitratana S; Boonthanom A; Wongwaisayawan H
    J Med Assoc Thai; 1984 Jul; 67(7):404-7. PubMed ID: 6512448
    [No Abstract]   [Full Text] [Related]  

  • 2. Diamino diphenyl sulfone in leprosy chemoprophylaxis.
    Sharma DR
    Indian Pediatr; 1971 May; 8(5):215-6. PubMed ID: 5095253
    [No Abstract]   [Full Text] [Related]  

  • 3. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S; Rege VL; Sehgal VN
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 6. Malaria, leprosy and dapsone.
    Saha K; Kapoor L; Arora VM; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dapsone-induced photodermatitis in a patient with leprosy].
    Fumey SM
    Z Hautkr; 1988 Jan; 63(1):53-4. PubMed ID: 3354248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of aspirin and chloramphenicol in normal and leprotic patients before and after dapsone therapy.
    Garg SK; Kumar B; Shukla VK; Bakaya V; Lal R; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):204-5. PubMed ID: 3403099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance in Nepali leprosy patients.
    Butlin CR; Neupane KD; Failbus SS; Morgan A; Britton WJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):136-41. PubMed ID: 8690972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone induced motor polyneuropathy.
    Jacob AJ; Rajendran A; Menezes J; Vaz M
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):341-3. PubMed ID: 1332194
    [No Abstract]   [Full Text] [Related]  

  • 17. The neurotoxicity of dapsone.
    Daneshmend TK
    Adverse Drug React Acute Poisoning Rev; 1984; 3(1):43-58. PubMed ID: 6091422
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report.
    Naik SS; Pandya SS
    Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapsone syndrome in Goa.
    Rege VL; Shukla P; Mascarenhas MF
    Indian J Lepr; 1994; 66(1):59-64. PubMed ID: 7983393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemolytic effects of DDS in leprosy patients.
    Khaire DS; Magar NG
    Indian J Med Res; 1972 Oct; 60(10):1510-9. PubMed ID: 4661662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.